Literature DB >> 22303578

MTHFR C677T polymorphism, homocysteine and B-vitamins status in a sample of Chinese and Malay subjects in Universiti Putra Malaysia.

S C Choo1, S P Loh, G L Khor, M N Sabariah, R Rozita.   

Abstract

INTRODUCTION: Methylenetetrahydrofolate reductase (MTHFR) C677T is involved in folate and homocysteine metabolism. Disruption in the activity of this enzyme will alter their levels in the body.
METHODOLOGY: This study assessed MTHFR C677T polymorphism and its relationship with serum homocysteine and B-vitamins levels in a sample of Chinese and Malays subjects in UPM, Serdang. One hundred subjects were randomly selected from among the university population. Folate, vitamin B12, B6, and homocysteine levels were determined using MBA, ECLIA, and HPLC, respectively. PCR coupled with HinfI digestion was used for detection of MTHFR C677T polymorphism.
RESULTS: The frequency of T allele was higher in the Chinese subjects (0.40) compared to the Malay (0.14). Folate, vitamin B12 and B6 levels were highest in the wild genotype in both ethnic groups. Subjects with heterozygous and homozygous genotype showed the highest homocysteine levels. The serum folate and homocysteine were mainly affected by homozygous genotype.
CONCLUSION: MTHFR C677T polymorphism plays an important role in influencing the folate and homocysteine metabolism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22303578

Source DB:  PubMed          Journal:  Malays J Nutr        ISSN: 1394-035X


  2 in total

1.  Genetic epidemiology of pharmacogenetic variants in South East Asian Malays using whole-genome sequences.

Authors:  A Sivadas; M Z Salleh; L K Teh; V Scaria
Journal:  Pharmacogenomics J       Date:  2016-05-31       Impact factor: 3.550

2.  Is the C677T polymorphism in methylenetetrahydrofolate reductase gene or plasma homocysteine a risk factor for diabetic peripheral neuropathy in Chinese individuals?

Authors:  Hongli Wang; Dongsheng Fan; Tianpei Hong
Journal:  Neural Regen Res       Date:  2012-10-25       Impact factor: 5.135

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.